Department of Medicine, Immunology Institute, Mount Sinai School of Medicine, 1425 Madison Avenue, New York, NY 10029, USA.
Immunol Res. 2012 Dec;54(1-3):233-46. doi: 10.1007/s12026-012-8329-z.
The pathway of V(D)J recombination was discovered almost three decades ago. Yet it continues to baffle scientists because of its inherent complexity and the multiple layers of regulation that are required to efficiently generate a diverse repertoire of T and B cells. The non-homologous end-joining (NHEJ) DNA repair pathway is an integral part of the V(D)J reaction, and its numerous players perform critical functions in generating this vast diversity, while ensuring genomic stability. In this review, we summarize the efforts of a number of laboratories including ours in providing the mechanisms of V(D)J regulation with a focus on the NHEJ pathway. This involves discovering new players, unraveling unknown roles for known components, and understanding how deregulation of these pathways contributes to generation of primary immunodeficiencies. A long-standing interest of our laboratory has been to elucidate various mechanisms that control RAG activity. Our recent work has focused on understanding the multiple protein-protein interactions and protein-DNA interactions during V(D)J recombination, which allow efficient and regulated generation of the antigen receptors. Exploring how deregulation of this process contributes to immunodeficiencies also continues to be an important area of research for our group.
V(D)J 重组途径几乎在三十年前就被发现了。但由于其固有的复杂性和高效产生多样化 T 细胞和 B 细胞所需的多层次调控,它仍然让科学家感到困惑。非同源末端连接(NHEJ)DNA 修复途径是 V(D)J 反应的一个组成部分,其众多参与者在产生这种多样性的同时,确保基因组的稳定性方面发挥着关键作用。在这篇综述中,我们总结了包括我们实验室在内的许多实验室的努力,提供了 V(D)J 调控的机制,重点是 NHEJ 途径。这包括发现新的参与者,揭示已知成分的未知作用,以及了解这些途径的失调如何导致原发性免疫缺陷的产生。我们实验室的长期兴趣之一是阐明控制 RAG 活性的各种机制。我们最近的工作集中在理解 V(D)J 重组过程中的多种蛋白质-蛋白质相互作用和蛋白质-DNA 相互作用,这些相互作用允许有效和受调控的抗原受体产生。探索这个过程的失调如何导致免疫缺陷也是我们小组的一个重要研究领域。